Table 1.

Experimental groups designed according to treatment plan

Group	Description
I	Infected non-treated control group
Infected and treated groups
II	albendazole full-dose (50 mg/kg)
III	albendazole half-dose (25 mg/kg)
IV	albendazole full-dose conjugated chitosan nanoparticles (50 mg/kg)
V	albendazole half-dose conjugated chitosan nanoparticles (25 mg/kg)
VI	Chitosan (50 mg/kg)
VII	chitosan nanoparticles (50 mg/kg)